Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Richard C Lauer"'
Autor:
Richard C Lauer, Marc Barry, Tracey L Smith, Andrew Maltez Thomas, Jin Wu, Ruofei Du, Ji-Hyun Lee, Arpit Rao, Andrey S Dobroff, Marco A Arap, Diana N Nunes, Israel T Silva, Emmanuel Dias-Neto, Isan Chen, Dennis J McCance, Webster K Cavenee, Renata Pasqualini, Wadih Arap
Publikováno v:
eLife, Vol 12 (2023)
Background: We have previously shown that the long non-coding (lnc)RNA prostate cancer associated 3 (PCA3; formerly prostate cancer antigen 3) functions as a trans-dominant negative oncogene by targeting the previously unrecognized prostate cancer su
Externí odkaz:
https://doaj.org/article/54de7b4374ee4770b8c53468739cf642
Autor:
Nick Crozier, Shenthol Sasankan, Bernard Tawfik, Janet Abernathy, Neda Hashemi-Sadraei, Richard C. Lauer, Ronald Kittson, Zoneddy Dayao
Publikováno v:
JCO Oncology Practice. 17:e1935-e1942
PURPOSE: Many factors contribute to long wait times for patients on the day of their chemotherapy infusion appointments. Longer wait time leads to nonoptimal care, increased costs, and decreased patient satisfaction. We conducted a quality improvemen
Autor:
Marc Barry, Richard C Lauer, Tracey L Smith, Andrew Maltez Thomas, Jin Wu, Ruofei Du, Ji-Hyun Lee, Arpit Rao, Andrey S Dobroff, Marco A Arap, Diana N Nunes, Israel T Silva, Emmanuel Dias-Neto, Isan Chen, Dennis J McCance, Webster K Cavenee, Renata Pasqualini, Wadih Arap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::244475c99f1e87c2c2c8a71571188031
https://doi.org/10.7554/elife.81929.sa2
https://doi.org/10.7554/elife.81929.sa2
Autor:
Harmony Bowles, Zoneddy Dayao, Janet Abernathy, Neda Hashemi, Richard C. Lauer, Bernard Tawfik
Publikováno v:
JCO Oncology Practice. 16:e1209-e1215
PURPOSE: The numbers and types of oral oncolytics in oncology are expanding rapidly. Oral oncolytics have serious adverse effects, and pharmacist-driven patient education has the potential to reduce adverse events. The University of New Mexico Compre
Autor:
Bryce Chackerian, Renata Pasqualini, Cosette M. Wheeler, Ricardo J. Giordano, Israel Tojal da Silva, Wadih Arap, Richard C. Lauer, Emmanuel Dias-Neto, Webster K. Cavenee, Richard L. Sidman, Serena Marchiò, Diana N. Nunes, Marc Barry, André Azevedo Reis Teixeira
Publikováno v:
EMBO Molecular Medicine
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Prostate cancer, the most frequent type of cancer in men, is surpassed only by lung cancer in causing cancer‐related death. Despite major progress in defining the mutational landscape of this tumor, its etiology remains obscure. The intronic long
Autor:
Neda Hashemi-Sadraei, Bernard Tawfik, Ronald Kittson, Janet Abernathy, Shenthol Sasankan, Zoneddy Dayao, Nick Crozier, Sandra Peacock, Andrea Cox, Richard C. Lauer
Publikováno v:
Journal of Clinical Oncology. 38:e14042-e14042
e14042 Background: Nationwide, many cancer centers experience challenges with infusion center efficiency while maintaining high safety standards. Many factors contribute to long wait times for patients on the day of their infusion appointments. At Un
Autor:
L. Ponsky, William Kevin Kelly, Hristos Z. Kaimakliotis, Edouard J. Trabulsi, Adam Calaway, Timothy A. Masterson, Richard C. Lauer, Pingfu Fu, Joel Picus, Nabil Adra, Christopher J. Hoimes, Michael O. Koch, Cheryl Eitman, Zachary L. Smith, Gordon Goolamier, Radhika Walling, Elizabeth Sonderman
Publikováno v:
Journal of Clinical Oncology. 38:5019-5019
5019 Background: Patients (pts) with laUC who are C-ineligible have inferior survival compared to counterparts who receive C based N-therapy and have a pathologic response at radical cystectomy (RC). Cohort 2 (C2) of the GU14-188 trial is designed to
Autor:
Tiffany Menhorn, Bernard Tawfik, Neda Hashemi-Sadraei, Amy Zarick-Jones, Richard C. Lauer, Harmony Bowles, Zoneddy Dayao, Nick Crozier, Shenthol Sasankan, Moises Harari Turquie
Publikováno v:
Journal of Clinical Oncology. 38:e19212-e19212
e19212 Background: Oral oncolytics therapy use has been exponentially growing over the last several years necessitating education and monitoring. Pharmacy driven interventions have been shown to increase side effects detection, mitigation and ensure
Autor:
Charles L. Wiggins, Amy Gundelach, Bernard Tawfik, Zoneddy Dayao, Janet Abernathy, Richard C. Lauer
Publikováno v:
Journal of Global Oncology. 5:69-69
69 Background: The Institute of Medicine endorses delivery of survivorship care plans (SCPs) to the growing number of cancer survivors in order to improve the coordination of care between oncologists and primary care providers (PCPs). In response, th
Autor:
Christopher J. Hoimes, Noah M. Hahn, Petros Grivas, Joaquim Bellmunt, Guru Sonpavde, Saby George, Tim Breen, Meredith M. Regan, Kirsten Anderson, Joel Picus, Aly-Khan A. Lalani, Cindy Jacobs, Richard C. Lauer, Arjun Vasant Balar, Lillian Werner, Robert S. Alter, Toni K. Choueiri, Ajjai Alva, Jonathan E. Rosenberg, Sumanta K. Pal, Jean H. Hoffman-Censits, Elizabeth A. Guancial, Constantine Albany, Mark N. Stein
Publikováno v:
British Journal of Cancer
Background A randomised study to assess the addition of apatorsen, an antisense oligonucleotide that inhibits Hsp27 expression, to docetaxel in patients with metastatic urothelial carcinoma (mUC) relapsed after prior platinum-based chemotherapy. Meth